What smart money is saying about Xeris Biopharma
XERS
No fund has written a full thesis on Xeris Biopharma in our archive, but 2 fund letters report a position in it — most recently Granahan Investment Management Microcap Growth Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
2
Reported positions
0
Bought
1
Sold
2
Letters
Position history
Every position in Xeris Biopharma on record in the archive was reported in Q3 2026, across 2 fund letters — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 1 | 0 |
Fund activity · 2 positions · 1 move
- September 2026
Listed in Granahan Investment Management Microcap Growth Strategy’s reported holdings.
Xeris Biopharma - September 2026
“We trimmed to manage position size.”
Xeris Biopharma
Read the letters behind these Xeris Biopharma positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger